Everolimus

1:31
Achieving better response rates in metastatic RCC
Bradley McGregor
2:16
The agents at the forefront of kidney cancer treatment
Michael Atkins
5:57
Current landscape and future direction in systemic therapy for renal cell carcinoma (RCC)
Susanne Osanto
1:11
Results of trial of ribociclib with everolimus and exemestane in breast cancer
Mafalda Olivera
4:12
CABOSUN trial of cabozantinib – could it change how we treat frontline RCC?
Toni Choueiri
1:12
Cabozantinib for advanced renal cell carcinoma: the METEOR and CABOSUN trials
Sumanta Pal
1:40
Phase III METEOR trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
Toni Choueiri
1:03
AZD2014 for treating ER+ metastatic breast cancer – mode of action and trial results
Erika Hamilton
3:52
CheckMate 025: Phase 3 trial of nivolumab for advanced kidney cancer
Padmanee Sharma
2:31
Changing the standard of care in previously treated metastatic renal cell carcinoma
Laurence Albiges
The content of VJOncology is intended for healthcare professionals